Insider · CIK 0001923843
Ann Cohen
Files at NAGE (Niagen Bioscience, Inc.). First filing -, latest -.
Ann Cohen files SEC Form 4 as director at NAGE (Niagen Bioscience, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ann Cohen has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | NAGE Niagen Bioscience, Inc. | AGrant or award Stock Option (right to buy)derivative | +31,746 | $0.00 | $0 | 31,746 | Jun 26, 2026 |
| Jun 24, 2025 | NAGE Niagen Bioscience, Inc. | AGrant or award Stock Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jun 25, 2025 |
Questions about Ann Cohen
Answered from the filings on this page, as of the latest one.
Is Ann Cohen buying or selling?
Ann Cohen has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ann Cohen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ann Cohen has 0.
Where does Ann Cohen file Form 4?
Ann Cohen has filed Form 4 at NAGE (Niagen Bioscience, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.